Efficacy of azithromycin in severe asthma from the AMAZES randomised trial.

Peter Gerard GibsonIan A YangJohn W UphamPaul N ReynoldsSandra HodgeAlan L JamesChristine JenkinsMatthew J PetersGuy B MarksMelissa BaraketHeather PowellJodie L Simpson

Published in: ERJ open research (2019)

Long-term, low-dose azithromycin reduced asthma exacerbations and improved the quality of life in patients with severe asthma, regardless of how this was defined. These data support the addition of azithromycin as a treatment option for patients with severe asthma.

Keyphrases

low dose
chronic obstructive pulmonary disease
cystic fibrosis
lung function
high dose
study protocol
clinical trial
allergic rhinitis
data analysis
deep learning